All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Orphan Drugs

Author(s): Meera Sumanth, S Parasher

As per the United States Food and Drug Administration, orphan drugs are defined as drugs used in diseases or circumstances which occur so infrequently in USA, that there is no reasonable expectation that the cost of developing and making available, a drug for such disease or condition will be recovered from its sales in USA. In this article, the current state of orphan drugs in different countries and the benefits provided by the drug authorities/government of the country for the development of drugs for rare disease is discussed.